Matrix Capital Management Company’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,959,973	Closed	-$21.1M	–	3
2025 Q3	$21.1M	Hold	13,959,973	–	–	19.75%	3
2025 Q2	$16.2M	Hold	13,959,973	–	–	7.27%	4
2025 Q1	$22.2M	Hold	13,959,973	–	–	6.39%	4
2024 Q4	$42.3M	Hold	13,959,973	–	–	1.97%	5
2024 Q3	$51.4M	Hold	13,959,973	–	–	2.45%	5
2024 Q2	$57.1M	Hold	13,959,973	–	–	0.43%	15
2024 Q1	$220M	Hold	13,959,973	–	–	2.04%	11
2023 Q4	$211M	Hold	13,959,973	–	–	2.18%	11
2023 Q3	$280M	Hold	13,959,973	–	–	3.36%	11
2023 Q2	$394M	Buy	13,959,973 +4,760,000	+52%	+$114M	4.58%	8
2023 Q1	$158M	Hold	9,199,973	–	–	2.15%	10
2022 Q4	$185M	Hold	9,199,973	–	–	3.54%	10
2022 Q3	$199M	Hold	9,199,973	–	–	3.81%	11
2022 Q2	$259M	Buy	9,199,973 +4,850,694	+112%	+$128M	5.86%	8
2022 Q1	$201M	Hold	4,349,279	–	–	2.41%	15
2021 Q4	$366M	Hold	4,349,279	–	–	4.07%	13
2021 Q3	$290M	Buy	4,349,279 +248,540	+6%	+$14.3M	3.3%	13
2021 Q2	$218M	Buy	4,100,739 +279,000	+7%	+$14.9M	2.38%	17
2021 Q1	$166M	Hold	3,821,739	–	–	1.91%	19
2020 Q4	$199M	Hold	3,821,739	–	–	2.15%	18
2020 Q3	$125M	Hold	3,821,739	–	–	1.66%	19
2020 Q2	$184M	Buy	+3,821,739	New	+$147M	2.86%	15